Home › Compare › PEARW vs NOBL

PEARW vs NOBL: Dividend Comparison 2026

PEARW yields 33898.31% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEARW wins by $9.963396520724352e+21M in total portfolio value
10 years
PEARW
PEARW
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full PEARW calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — PEARW vs NOBL

📍 PEARW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARWNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEARW + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PEARW pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEARW
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, PEARW beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEARW + NOBL for your $10,000?

PEARW: 50%NOBL: 50%
100% NOBL50/50100% PEARW
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEARW right now

PEARW
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-9.0
Piotroski
2/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEARW buys
0
NOBL buys
0
No recent congressional trades found for PEARW or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARWNOBL
Forward yield33898.31% ✓2.14%
Annual dividend / share$2.00$2.27 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$9.963396520724352e+21M$22.8K ✓
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00 ✓$246.19
Total dividends collected$9.959616773768018e+21M ✓$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PEARW vs NOBL ($10,000, DRIP)

YearPEARW PortfolioPEARW Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$3,400,531$3,389,830.51$10,914$214.34+$3.39M → PEARW
2$1,080,949,041$1,077,310,473.14$11,897$218.63+$1080.94M → PEARW
3$321,205,007,173$320,048,391,699.27$12,952$222.72+$321204.99M → PEARW
4$89,224,694,578,678$88,881,005,221,002.70$14,086$226.62+$89224694.56M → PEARW
5$23,169,738,996,241,900$23,074,268,573,042,710.00$15,302$230.33+$23169738996.23M → PEARW
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$16,607$233.85+$5624691175493.51M → PEARW
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$18,007$237.18+$1276516462323700.25M → PEARW
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$19,508$240.35+$270840549707403520.00M → PEARW
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$21,116$243.35+$53724262376359346176.00M → PEARW
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$22,841$246.19+$9.963396520724352e+21M → PEARW

PEARW vs NOBL: Complete Analysis 2026

PEARW — Stock

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

Full PEARW Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this PEARW vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEARW vs SCHDPEARW vs JEPIPEARW vs OPEARW vs KOPEARW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.